Is duration of preoperative anti-tuberculosis treatment a risk factor for postoperative relapse or non-healing of spinal tuberculosis?
- PMID: 26951176
- DOI: 10.1007/s00586-016-4496-2
Is duration of preoperative anti-tuberculosis treatment a risk factor for postoperative relapse or non-healing of spinal tuberculosis?
Abstract
Purpose: This study evaluated the relationship between spinal TB postoperative recurrence or non-healing and duration of preoperative anti-TB treatment (ATT).
Methods: From January 2004 to January 2013, patients who underwent surgery for spinal TB and met this study's inclusion criteria were retrospectively reviewed. Observed parameters were age, sex, initial ESR, preoperative ESR, degree of ESR change, initial CRP, preoperative CRP, degree of CRP change, duration of preoperative ATT, surgical approach, presence of internal fixation, location of spinal lesion, number of involved segments, duration of operation, and intraoperative blood loss. The data were analyzed by univariate and multivariate analyses for spinal TB recurrence or non-healing to determine related risk factors.
Results: A total of 223 patients met the inclusion criteria. There were 84 female and 139 male patients with a mean age of 42.2 years (range 2-85 years). The follow-up period was 18-72 months (average 28.7 months). Among 223 patients observed, 23 patients had postoperative relapse or non-healing (10.3 %) during the follow-up period. Statistical analysis indicated that the location of a spinal lesion was significantly associated with postoperative relapse or non-healing. Risk of postoperative relapse or non-healing in thoracolumbar TB was 2.524-fold (95 % CI 1.026-6.580) that of lumbosacral TB.
Conclusions: Duration of preoperative ATT may not be a risk factor for postoperative recurrence or non-healing of spinal TB. Junctional zones such as the lumbosacral and thoracolumbar junction have a higher recurrence rate than non junctional.
Keywords: Preoperative anti-TB treatment; Retrospective study; Risk factor; Spinal tuberculosis.
Comment in
-
Is duration of preoperative anti-tuberculosis treatment a risk factor for postoperative relapse or non-healing of spinal tuberculosis: response to comments by Li et al.Eur Spine J. 2016 Sep;25(9):3008-9. doi: 10.1007/s00586-016-4572-7. Epub 2016 Apr 20. Eur Spine J. 2016. PMID: 27098426 No abstract available.
-
Comments on Ren et al.: Is duration of preoperative anti-tuberculosis treatment a risk factor for postoperative relapse or non-healing of spinal tuberculosis?Eur Spine J. 2016 Sep;25(9):3007. doi: 10.1007/s00586-016-4568-3. Epub 2016 May 12. Eur Spine J. 2016. PMID: 27172920 No abstract available.
Similar articles
-
Analysis of changing paradigms of management in 179 patients with spinal tuberculosis over a 12-year period and proposal of a new management algorithm.World Neurosurg. 2013 Jul-Aug;80(1-2):190-203. doi: 10.1016/j.wneu.2012.12.019. Epub 2013 Jan 22. World Neurosurg. 2013. PMID: 23348057
-
Changing trends in duration of treatment of musculoskeletal and spinal tuberculosis- long term experience in a tertiary care teaching hospital.Indian J Tuberc. 2025 Apr;72(2):266-272. doi: 10.1016/j.ijtb.2024.05.006. Epub 2024 May 19. Indian J Tuberc. 2025. PMID: 40518224 Review.
-
Outcomes and Treatment of Lumbosacral Spinal Tuberculosis: A Retrospective Study of 53 Patients.PLoS One. 2015 Jun 29;10(6):e0130185. doi: 10.1371/journal.pone.0130185. eCollection 2015. PLoS One. 2015. PMID: 26121685 Free PMC article.
-
Comparison of single posterior debridement, bone grafting and instrumentation with single-stage anterior debridement, bone grafting and posterior instrumentation in the treatment of thoracic and thoracolumbar spinal tuberculosis.BMC Surg. 2018 Sep 3;18(1):71. doi: 10.1186/s12893-018-0405-4. BMC Surg. 2018. PMID: 30176880 Free PMC article.
-
Chemotherapeutic treatment for spinal tuberculosis.Int J Tuberc Lung Dis. 2002 Mar;6(3):259-65. Int J Tuberc Lung Dis. 2002. PMID: 11934144 Review.
Cited by
-
Comments on Ren et al.: Is duration of preoperative anti-tuberculosis treatment a risk factor for postoperative relapse or non-healing of spinal tuberculosis?Eur Spine J. 2016 Sep;25(9):3007. doi: 10.1007/s00586-016-4568-3. Epub 2016 May 12. Eur Spine J. 2016. PMID: 27172920 No abstract available.
-
Is duration of preoperative anti-tuberculosis treatment a risk factor for postoperative relapse or non-healing of spinal tuberculosis: response to comments by Li et al.Eur Spine J. 2016 Sep;25(9):3008-9. doi: 10.1007/s00586-016-4572-7. Epub 2016 Apr 20. Eur Spine J. 2016. PMID: 27098426 No abstract available.
-
Mid- and Long-Term Efficacy of Surgical Treatment of L1-2 Vertebral Tuberculosis with Subdiaphragmatic Extraperitoneal Approach.Med Sci Monit. 2021 Jun 17;27:e932284. doi: 10.12659/MSM.932284. Med Sci Monit. 2021. PMID: 34135300 Free PMC article.
-
Surgical approach and management outcomes for junction tuberculous spondylitis: a retrospective study of 77 patients.J Orthop Surg Res. 2018 Dec 6;13(1):312. doi: 10.1186/s13018-018-1021-9. J Orthop Surg Res. 2018. PMID: 30522509 Free PMC article.
-
Subjacent Disease in an Operated Case of Spinal Tuberculosis: A Case Report and Literature Review.J Orthop Case Rep. 2023 Oct;13(10):16-19. doi: 10.13107/jocr.2023.v13.i10.3918. J Orthop Case Rep. 2023. PMID: 37885630 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous